Our research revealed that ADIPOR1 and ADIPOR2 are dysregulated in a wide range of tumors, and that they play critical roles in anti-tumor immunity as well as drug sensitivity, which indicated that adipose tissues might affect tumor tissues via interacting with AdipoR1/2 receptors. Here, ADIPOR1 is linked to neoplasm.